Volume | 432,882 |
|
|||||
News | - | ||||||
Day High | 75.98 | Low High |
|||||
Day Low | 74.76 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
75.91 | 74.76 | 75.98 | 75.57 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,592 | 432,882 | $ 75.21 | $ 32,558,684 | - | 64.02 - 83.13 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:11:23 | 1 | $ 74.88 | USD |
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.6B | 234.73M | - | 4.05B | 456M | 1.94 | 38.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 76.28 | 76.48 | 74.6401 | 75.66 | 1,287,646 | -1.40 | -1.84% |
1 Month | 76.905 | 79.75 | 74.53 | 75.86 | 1,399,219 | -2.03 | -2.63% |
3 Months | 73.69 | 79.75 | 73.05 | 76.02 | 1,576,426 | 1.19 | 1.61% |
6 Months | 71.95 | 79.75 | 67.5921 | 73.81 | 1,742,490 | 2.93 | 4.07% |
1 Year | 82.61 | 83.13 | 64.02 | 74.25 | 1,737,609 | -7.73 | -9.36% |
3 Years | 63.14 | 87.88 | 59.78 | 73.39 | 1,717,366 | 11.74 | 18.59% |
5 Years | 44.76 | 87.88 | 26.49 | 65.79 | 1,895,678 | 30.12 | 67.29% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |